63 related articles for article (PubMed ID: 9383574)
1. Structure-activity relationships in cell culture.
Wagner RW
Ciba Found Symp; 1997; 209():142-54; discussion 154-7. PubMed ID: 9383574
[TBL] [Abstract][Full Text] [Related]
2. Antisense gene inhibition by C-5-substituted deoxyuridine-containing oligodeoxynucleotides.
Gutierrez AJ; Matteucci MD; Grant D; Matsumura S; Wagner RW; Froehler BC
Biochemistry; 1997 Jan; 36(4):743-8. PubMed ID: 9020771
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of gene function using C-5 propyne antisense oligonucleotides.
Flanagan WM; Su LL; Wagner RW
Nat Biotechnol; 1996 Sep; 14(9):1139-45. PubMed ID: 9631067
[TBL] [Abstract][Full Text] [Related]
4. Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides.
Moulds C; Lewis JG; Froehler BC; Grant D; Huang T; Milligan JF; Matteucci MD; Wagner RW
Biochemistry; 1995 Apr; 34(15):5044-53. PubMed ID: 7536034
[TBL] [Abstract][Full Text] [Related]
5. Efficient and isoform-selective inhibition of cellular gene expression by peptide nucleic acids.
Liu Y; Braasch DA; Nulf CJ; Corey DR
Biochemistry; 2004 Feb; 43(7):1921-7. PubMed ID: 14967032
[TBL] [Abstract][Full Text] [Related]
6. Potent and selective inhibition of gene expression by an antisense heptanucleotide.
Wagner RW; Matteucci MD; Grant D; Huang T; Froehler BC
Nat Biotechnol; 1996 Jul; 14(7):840-4. PubMed ID: 9631007
[TBL] [Abstract][Full Text] [Related]
7. [Antisense oligonucleotides with antitumor activity].
Otvös L; Sági G
Magy Onkol; 2004; 48(3):221-7. PubMed ID: 15520872
[TBL] [Abstract][Full Text] [Related]
8. Application of antisense oligonucleotides for gene functionalization and target validation.
Bennett CF; Cowsert LM
Curr Opin Mol Ther; 1999 Jun; 1(3):359-71. PubMed ID: 11713801
[TBL] [Abstract][Full Text] [Related]
9. [Antisense oligonucleotides inhibit c-myc and PCNA expression in the vascular smooth muscle cells].
Bian J; Zhang B; Chen S
Zhonghua Yi Xue Za Zhi; 1999 Jan; 79(1):10-4. PubMed ID: 11600998
[TBL] [Abstract][Full Text] [Related]
10. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
Nesterova M; Noguchi K; Park YG; Lee YN; Cho-Chung YS
Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726
[TBL] [Abstract][Full Text] [Related]
11. Potent in vivo antiangiogenic effects of GS-101 (5'-TATCCGGAGGGCTCGCCATGCTGCT-3'), an antisense oligonucleotide preventing the expression of insulin receptor substrate-1.
Al-Mahmood S; Colin S; Farhat N; Thorin E; Steverlynck C; Chemtob S
J Pharmacol Exp Ther; 2009 May; 329(2):496-504. PubMed ID: 19208899
[TBL] [Abstract][Full Text] [Related]
12. Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines.
Wagner RW; Matteucci MD; Lewis JG; Gutierrez AJ; Moulds C; Froehler BC
Science; 1993 Jun; 260(5113):1510-3. PubMed ID: 7684856
[TBL] [Abstract][Full Text] [Related]
13. Cellular penetration and antisense activity by a phenoxazine-substituted heptanucleotide.
Flanagan WM; Wagner RW; Grant D; Lin KY; Matteucci MD
Nat Biotechnol; 1999 Jan; 17(1):48-52. PubMed ID: 9920268
[TBL] [Abstract][Full Text] [Related]
14. Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy.
Cho YS; Cho-Chung YS
Clin Cancer Res; 2003 Mar; 9(3):1171-8. PubMed ID: 12631623
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of dengue virus by novel, modified antisense oligonucleotides.
Raviprakash K; Liu K; Matteucci M; Wagner R; Riffenburgh R; Carl M
J Virol; 1995 Jan; 69(1):69-74. PubMed ID: 7983769
[TBL] [Abstract][Full Text] [Related]
16. Antisense inhibition of osteogenic protein 1 disturbs human articular cartilage integrity.
Söder S; Hakimiyan A; Rueger DC; Kuettner KE; Aigner T; Chubinskaya S
Arthritis Rheum; 2005 Feb; 52(2):468-78. PubMed ID: 15693015
[TBL] [Abstract][Full Text] [Related]
17. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
[TBL] [Abstract][Full Text] [Related]
18. Characterization of antisense oligonucleotides comprising 2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (FANA): specificity, potency, and duration of activity.
Ferrari N; Bergeron D; Tedeschi AL; Mangos MM; Paquet L; Renzi PM; Damha MJ
Ann N Y Acad Sci; 2006 Oct; 1082():91-102. PubMed ID: 17145930
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells.
Aukunuru JV; Ayalasomayajula SP; Kompella UB
J Pharm Pharmacol; 2003 Sep; 55(9):1199-206. PubMed ID: 14604462
[TBL] [Abstract][Full Text] [Related]
20. Novel chemically modified oligonucleotides provide potent inhibition of P-glycoprotein expression.
Alahari SK; DeLong R; Fisher MH; Dean NM; Viliet P; Juliano RL
J Pharmacol Exp Ther; 1998 Jul; 286(1):419-28. PubMed ID: 9655887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
